This Arizona company that wants to raise millions by going public has already implanted thousands of its temporary artificial ...

Revolutionary balloon and stent procedure reduces recovery time from weeks to days, transforming treatment for patients with mechanical heart pumps.

The building will be home to the company’s Cardiovascular Institute and is expected to be open and operational this summer.

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

The maker of the FDA’s only approved total artificial heart has outlined plans to go public, with a $12 million IPO, ...

Aortic valve stenosis” is an often-overlooked condition and a growing health concern in ageing societies such as Thailand.

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...

At two years of follow-up, patients with a poorly functioning tricuspid valve in the heart who received the best available ...

CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Gearing Up for Phase 3 Trial of Tecarfarin Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) is a biopharmaceutical company developing tecarfarin, a ...

Developers of cardiology drugs and devices will be back in the spotlight this weekend when the annual scientific meeting of ...

In Australia, an artificial heart made of titanium kept a man alive for 100 days while a donor heart was eventually found, marking the longest period that someone has survived on the innovation.